Global health official warns Australia about threat of coronavirus 'vaccine nationalism'

As dozens of companies and universities rush to develop a coronavirus vaccine, the USA will also have to grapple with who will get a vaccine first once it's been approved by the Food and Drug Administration.

Ministers say plans are in place to roll out a Covid-19 vaccine to 30 million people in the United Kingdom by September if human trials are successful.

We ask a virologist how likely this timeline is and what it might mean for the United States if they succeed.

As the effects of coronavirus intensify, countries all over the world have started to implement measures to develop a vaccine that could minimize the loss arising from this crisis.

At the moment, we should be as realistic as possible and assume that a vaccine won't be available until early 2021 at the absolute earliest.

VMIC was established by Oxford, Imperial and London School of Hygiene and Tropical Medicine with support from MSD, Johnson & Johnson, and GE Healthcare and funding from UK Research and Innovation.

It comes as concerns are building that Australia may not get quick access to any COVID-19 vaccine developed overseas with powerful foreign countries fighting to treat their own citizens first.

"The first clinical trial of the Oxford vaccine is progressing well with all phase one participants having received their vaccine dose on schedule earlier this week".

"The speed at which Oxford University has designed and organised these complex trials is genuinely unprecedented".

"CEPI (Coalition for Epidemic Preparedness Innovations) was set up exactly for that goal - to really encourage a global, collaborative effort for dealing with pandemics, and particularly and specifically in relation to vaccine development", he said.

She says 94 per cent of vaccine candidates fail, but there are 130 groups around the world racing to find a solution.

She said a "it's all good" attitude would reduce social distancing and could cause a "really bad outcome" for the elderly and immunocompromised.

Business Secretary Alok Sharma revealed to the daily briefing that a deal had been confirmed for the commercialisation and manufacturing of the vaccine now being trialled at Oxford University. "And we will be working with the government on what some of those ideas might be".

"We're looking to get it by the end of the year if we can, maybe before", Trump said on Friday, according to NPR. However, these plans are still contingent upon the successful development of vaccines later this year.

CSL told News Corp its vaccine subsidiary Seqiris was already working with the University of Queensland and could produce its world leading COVID-19 vaccine candidate.

Related Articles